UK markets closed

Relief Therapeutics Holding SA (0QKQ.L)

LSE - LSE Delayed price. Currency in CHF
Add to watchlist
1.2800+0.0250 (+1.99%)
At close: 10:57AM BST
Full screen
Previous close1.2550
Bid0.0000 x N/A
Ask0.0000 x N/A
Day's range1.2800 - 1.2800
52-week range1.2800 - 8.2400
Avg. volume219
Market cap8.115M
Beta (5Y monthly)-14.15
PE ratio (TTM)N/A
EPS (TTM)-0.0100
Earnings date29 Apr 2024
Forward dividend & yieldN/A (N/A)
Ex-dividend dateN/A
1y target estN/A
  • GlobeNewswire

    Eton Pharmaceuticals Announces Acquisition of PKU GOLIKE® for Phenylketonuria

    PKU GOLIKE® is a commercial ultra-rare disease medical formula complementary to Eton's existing metabolic franchise and specialty call pointTransaction is expected to be accretive to 2024 earningsEstimated peak sales of more than $10 million annuallyU.S. phenylketonuria ("PKU") medical formula market estimated to be $100 million annually DEER PARK, Ill., March 22, 2024 (GLOBE NEWSWIRE) -- Eton Pharmaceuticals, Inc (“Eton” or the “Company”) (Nasdaq: ETON), an innovative pharmaceutical company foc